Abstract:Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth-leading cause of cancer-related death in North America. Matrix metalloproteinases (MMPs) have long been targeted as a potential anticancer therapy because of their seminal role in angiogenesis and extracellular matrix (ECM) degradation of tumor survival and invasion. However, the inhibition specificity to MMPs and the molecular-level understanding of the inhibition mechanism remain largely unresolved. Here, we found that endohedral metallofullerenol Gd@C 82 (OH) 22 can successfully inhibit the neoplastic activity with experiments at animal, tissue, and cellular levels. Gd@C 82 (OH) 22 effectively blocks tumor growth in human pancreatic cancer xenografts in a nude mouse model. Enzyme activity assays also show Gd@C 82 (OH) 22 not only suppresses the expression of MMPs but also significantly reduces their activities. We then applied large-scale molecular-dynamics simulations to illustrate the molecular mechanism by studying the Gd@C 82 (OH) 22 –MMP-9 interactions in atomic detail. Our data demonstrated that Gd@C 82 (OH) 22 inhibits MMP-9 mainly via an exocite interaction, whereas the well-known zinc catalytic site only plays a minimal role. Steered by nonspecific electrostatic, hydrophobic, and specific hydrogen-bonding interactions, Gd@C 82 (OH) 22 exhibits specific binding modes near the ligand-specificity loop S1′, thereby inhibiting MMP-9 activity. Both the suppression of MMP expression and specific binding mode make Gd@C 82 (OH) 22 a potentially more effective nanomedicine for pancreatic cancer than traditional medicines, which usually target the proteolytic sites directly but fail in selective inhibition. Our findings provide insights for de novo design of nanomedicines for fatal diseases such as pancreatic cancer.

Gd-Metallofullerenol Nanoparticles Cause Intracellular Accumulation of PDGFR-α and Morphology Alteration of Fibroblasts

Molecular Mechanism of Gd@C82(OH)22 Increasing Collagen Expression: Implication for Encaging Tumor

Regulation on Mechanical Properties of Collagen: Enhanced Bioactivities of Metallofullerol.

Gd-metallofullerenol Nanomaterial As Non-Toxic Breast Cancer Stem Cell-Specific Inhibitor

Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by Gd@C82(OH)22 and Its Implication for De Novo Design of Nanomedicine.

Dual Inhibitory Pathways of Metallofullerenol Gd@C82(OH)22 on Matrix Metalloproteinase-2: Molecular Insight into Drug-Like Nanomedicine

Gd@C82(OH)22 Nanoparticles Constrain Macrophages Migration into Tumor Tissue to Prevent Metastasis.

Photo-triggered Gadofullerene: Enhanced Cancer Therapy by Combining Tumor Vascular Disruption and Stimulation of Anti-Tumor Immune Responses

The Effect of Gd@C-82(Oh)(22) Nanoparticles on the Release of Th1/Th2 Cytokines and Induction of Tnf-Alpha Mediated Cellular Immunity

PDGF receptor-β-targeted copper-gadolinium-oxide self-assembled nanoclusters suppress tumor growth and metastasis via copper overload-mediated apoptosis and anti-angiogenesis

Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis.

Inhibition of CYP2C8 by Metallofullerenol Gd@C82(OH)22 Through Blocking Substrate Channels and Substrate Recognition Sites

Integrin-Mediated Signaling Contributes to Gadolinium-Containing-Particle-Promoted Cell Survival and G(1) to S Phase Cell Cycle Transition by Enhancing Focal Adhesion Formation

[Gd@C-82(Oh)(22)](N) Nanoparticles Inhibit The Migration And Adhesion Of Glioblastoma Cells

Metallofullerene Nanoparticles Promote Osteogenic Differentiation of Bone Marrow Stromal Cells Through BMP Signaling Pathway

Metallofullerol Nanoparticles with Low Toxicity Inhibit Tumor Growth by Induction of G0/G1 Arrest (retracted Article. See Vol. 8, Pg. 1356, 2013)

Gadolinium Chloride Promotes Proliferation of HEK293 Human Embryonic Kidney Cells by Activating EGFR/PI3K/Akt and MAPK Pathways

Polyhydroxylated Metallofullerenols Stimulate IL‐1β Secretion of Macrophage Through TLRs/MyD88/NF‐κB Pathway and NLRP3 Inflammasome Activation

Gd-metallofullerenol Drug Delivery System Mediated Macrophage Polarization Enhances the Efficiency of Chemotherapy

Polyhydroxylated Fullerenols Regulate Macrophage for Cancer Adoptive Immunotherapy and Greatly Inhibit the Tumor Metastasis.

Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer